Finally, the higher RRI values observed in patients who started SGLT2i treatment compared to those treated with GLP1-RA are in line with current diabetes management guidelines that recommend gliflozins as the first choice in patients with high CVR and cardiac and/or renal complications. Here, GLP1R is linked to diabetes mellitus.